Rapid drug detection test 1L15S3
for tricyclic antidepressantsurineblood

Rapid drug detection test - 1L15S3 - Boson Biotech Co., Ltd. - for tricyclic antidepressants / urine / blood
Rapid drug detection test - 1L15S3 - Boson Biotech Co., Ltd. - for tricyclic antidepressants / urine / blood
Add to favorites
Compare this product
 

Characteristics

Application domain
drug detection
Tested parameter
for tricyclic antidepressants
Sample type
urine, blood
Analysis mode
immunochromatographic
Format
cassette, strip
Result display time

5 min

Description

Rapid Tricyclic antidepressant (TCA) Test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of tricyclic anti-depressant in human urine specimens. Tricyclic antidepressants, also known now as cyclic antidepressants or TCAs, should be used cautiously in patients with seizures since they can increase the risk of seizures. TCAs may worsen urinary retention and narrow angle glaucoma. Abnormal heart rhythms and sexual dysfunction have also been associated with TCAs. Symptoms of overdose may include: sedation, difficulty thinking, hallucinations, serious changes in heart rhythm, low blood pressure, seizures, hyperthermia, and dilated pupils. TCA can be detected in your urine in 5 days after consumption. Some other medicines can interfere with this test, causing a false-positive for TCAs. These include carbamazepine, quetiapine, diphenhydramine, thioridazine, chlorpromazine, and cyclobenzaprine.

Catalogs

No catalogs are available for this product.

See all of Boson Biotech Co., Ltd.‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.